KRAS and neoplasm: The strong suppressive effects of the downregulation of K-Ras and downstream signaling in the glycolytic pathway via HIF-1α is evident in diverse tumor cells (Mazure et al., 1997; Fukuda et al., 2002; Gao et al., 2002).